CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 82 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,717 | -51.2% | 62,900 | -37.2% | 0.00% | – |
| Q2 2023 | $112,112 | -7.2% | 100,100 | -13.9% | 0.00% | – |
| Q1 2023 | $120,848 | -35.8% | 116,200 | -30.8% | 0.00% | -100.0% |
| Q4 2022 | $188,160 | -25.3% | 168,000 | -24.7% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | -52.6% | 223,000 | -38.4% | 0.00% | -50.0% |
| Q2 2022 | $532,000 | -64.7% | 361,900 | -45.0% | 0.00% | -50.0% |
| Q1 2022 | $1,508,000 | -37.7% | 658,300 | -25.2% | 0.00% | -33.3% |
| Q4 2021 | $2,420,000 | -60.1% | 879,900 | -13.0% | 0.01% | -62.5% |
| Q3 2021 | $6,068,000 | +25.9% | 1,011,400 | +2.2% | 0.02% | +23.1% |
| Q2 2021 | $4,821,000 | +199.4% | 990,000 | +51.9% | 0.01% | +225.0% |
| Q1 2021 | $1,610,000 | +1083.8% | 651,800 | +1208.8% | 0.00% | – |
| Q4 2020 | $136,000 | -14.5% | 49,800 | -51.7% | 0.00% | – |
| Q3 2020 | $159,000 | +467.9% | 103,100 | +415.5% | 0.00% | – |
| Q1 2019 | $28,000 | -77.0% | 20,000 | +75.4% | 0.00% | – |
| Q1 2018 | $122,000 | – | 11,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |